GraniteShares YieldBOOST Biotech ETF · $2M[…]
BIOYBIOY vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested
BIOYMeasureARKG
Returns · dividends reinvested
[…]Year to dateJan 1 → Nov 3+70.9%
[…]1 yearTotal return+59.0%
[…]3 years · per year$10,000 became […] · $22,262+30.6%
[…]5 years · per year$10,000 became […] · $6,586−8.0%
Cost and income
14.98%Expense ratio$1,498 · $75 a year on $10k · lower is better0.75%
33.84%Trailing 12-mo yield$3,384 · $0 a year on $10k0.00%
Risk · past year
[…]Worst dropSmaller is better−27.5%
[…]VolatilityLower is calmer45.8%
BIOYARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
1–1Level
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns